Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis CEO: We need to re-think the blockbuster
Fortune
Monday, March 4, 2013 - 10:42am
tags:
Novartis, Pharma CEOs, Joe Jimenez
Athersys' MultiStem Platform Tempts Big Pharma And Investors
Seeking Alpha
Monday, March 4, 2013 - 10:39am
tags:
Athersys, MultiStem, Pfizer, stem cells
Elan offers Tysabri dividend, dismisses Royalty offer
Reuters
Monday, March 4, 2013 - 10:38am
tags:
Elan, dividends, Tysabri, Royalty Pharma
Dense Fog Over Amarin's Earnings
Motley Fool
Sunday, March 3, 2013 - 11:49am
tags:
Amarin
Why Exelixis Is Ready to Rebound
Motley Fool
Sunday, March 3, 2013 - 11:48am
tags:
Exelixis
Coronado Biosciences: 2013 - Year Of The Worm
Seeking Alpha
Sunday, March 3, 2013 - 11:45am
tags:
TSO, autoimmune disease, multiple sclerosis, MS, Chron's Disease, ulcerative colitis, acute myeloid leukemia
Teva Calls 5.550% Senior Notes Due 2016 for Redemption
Pharmiweb
Sunday, March 3, 2013 - 11:38am
tags:
Teva Pharmaceuticals
3 Pharmaceutical Stocks to Sell Now
InvestorPlace
Sunday, March 3, 2013 - 11:33am
tags:
Corcept Therapeutics, Vivus, Cempra
Do These Pipeline Drugs Hold the Key to AbbVie's Future?
Motley Fool
Sunday, March 3, 2013 - 11:32am
tags:
AbbVie, GLPG0634, BT-061, rheumatoid arthritis, psoriasis
Eli Lilly Sues Genentech Seeking to Invalidate Cabilly Patents
Bloomberg
Sunday, March 3, 2013 - 11:30am
tags:
Eli Lilly, Genentech, Erbitux, patents, Patent Infringement, lawsuits
This Week in Biotech
Motley Fool
Sunday, March 3, 2013 - 11:27am
tags:
Dynavax, Zogenix, Optimer Pharmaceuticals, Affymax, Vivus
Salix Pharmaceuticals Price Target Raised to $53.00 at Brean Murray (SLXP)
Jags Report
Sunday, March 3, 2013 - 11:26am
tags:
Salix
US FDA accepts Sunovion's resubmitted NDA for Stedesa for review
Pharmabiz
Sunday, March 3, 2013 - 11:25am
tags:
Sunovion, epilepsy, Stedesa
Cerus Beats on Both Top and Bottom Lines
Motley Fool
Sunday, March 3, 2013 - 11:23am
tags:
Cerus, earnings
A Drug That's Ready to Lose
Motley Fool
Sunday, March 3, 2013 - 11:23am
tags:
Belviq, Arena Pharmaceuticals, obesity, weight loss
Celgene drug shown to be effective, safe in psoriasis trial
Reuters
Sunday, March 3, 2013 - 11:22am
tags:
Cellgene, psoriasis, apremilast
Medivation Earnings Call Nuggets: Gross to Net Conversion and the Pre-Chemo Market
Wall Street Cheat Street
Sunday, March 3, 2013 - 11:20am
tags:
Medivation, earnings
Are Short Sellers Right About Spectrum?
Motley Fool
Sunday, March 3, 2013 - 11:19am
tags:
Spectrum Pharmaceuticals
3 Bio-Pharmaceuticals Insiders Love
Motley Fool
Sunday, March 3, 2013 - 11:19am
tags:
MannKind, Merrimack Pharmaceuticals, Tesaro
Cellceutix - A Biotech To Consider For 2013
Seeking Alpha
Sunday, March 3, 2013 - 11:18am
tags:
Cellceutix

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.